Objective To investigate the endogenous inhibitor of nitric oxide synthase(NOS) asymmetric dimethylarginine(ADMA) in patients with essential hypertension(EH) and its clinical significance.

• 目的探讨血清非对称性二甲基精氨酸(ADMA)与原发性高血压(EH)的关系及其临床意义。方法选择62例EH患者和24例健康体检者,分别测定血清中ADMA和一氧化氮(NO)水平并进行比较。